Muhammad Wasim

Dr. Muhammad Wasim

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 April 2023 in Advanced Biology
Verified
Journal Article
Closed access
MWMuhammad Wasim
Muhammad Wasim
HKHaq Nawaz Khan
Haq Nawaz Khan
HAHina Ayesha
Hina Ayesha
FAFazli Rabbi Awan
Fazli Rabbi Awan


14 December 2021 in Journal of Pediatric Endocrinology and Metabolism
Verified
Journal Article
Closed access
MWMuhammad Wasim
Muhammad Wasim
HKHaq N. Khan
Haq N. Khan
HAHina Ayesha
Hina Ayesha
MIMazhar Iqbal
Mazhar Iqbal
ATAbdul Tawab
Abdul Tawab
FAFazli R. Awan
Fazli R. Awan
Background: Classical homocystinuria (HCU) is an autosomal recessive inborn error of metabolism, which is caused by the cystathionine-β-synthase (CBS: encoded by CBS) deficiency. Symptoms of untreated classical HCU patients include intellectual disability (ID), ectopia lentis and long limbs, along with elevated plasma methionine, and homocysteine. Methods: A total of 429 ID patients (age range: 1.6–23 years) were sampled from Northern areas of Punjab, Pakistan. Biochemical and genetic analyses were performed to find classical HCU disease in ID patients. Results: Biochemically, nine patients from seven unrelated families were identified with high levels of plasma methionine and homocysteine. Targeted exonic analysis of CBS confirmed seven causative homozygous mutations; of which three were novel missense mutations (c.451G>T; p.Gly151Trp, c.975G>C; p.Lys325Asn and c.1039 + 1G>T splicing), and four were recurrent variants (c.451 + 1G>A; IVS4 + 1 splicing, c.770C>T; p.Thr257Met, c.808_810del GAG; p.Glu270del and c.752T>C; p.Leu251Pro). Treatment of patients was initiated without further delay with pyridoxine, folic acid, cobalamin, and betaine as well as dietary protein restriction. The immediate impact was noticed in behavioral improvement, decreased irritability, improved black hair color, and socialization. Overall, health outcomes in this disorder depend on the age and symptomatology at the time of treatment initiation. Conclusions: With personalized treatment and care, such patients can reach their full potential of living as healthy a life as possible. This screening study is one of the pioneering initiatives in Pakistan which would help to minimize the burden of such treatable inborn errors of metabolism in the intellectually disabled patients.

16 September 2024 in Clinical Neuropharmacology
Verified
Journal Article
Closed access
MWMuhammad Wasim
Muhammad Wasim
SZSyeda Rehana Zia
Syeda Rehana Zia
SKSaara Ahmad Muddasir Khan
Saara Ahmad Muddasir Khan
Objectives: Neurological disorders represent a significant global health challenge, necessitating the exploration of novel therapeutic agents. Apigenin, a natural flavonoid abundantly found in various plants, has garnered attention for its potential neuroprotective properties. In this study, we employed molecular docking simulations to investigate the interaction between apigenin and key molecular targets associated with neurological disorders. Methods: The molecular docking analysis focused on receptors implicated in neuroinflammation, oxidative stress, and neurotransmission regulation. Results: Our results reveal a high binding affinity of apigenin towards critical targets, including GABA, mACh, nACh, NMDA, 5HTA, AMPA, insulin, and dopamine receptors. The findings suggest that apigenin may exert its neuroprotective effects through multifaceted mechanisms, including anti-inflammatory, antioxidant, and neurotransmission regulatory pathways. Additionally, the absence of adverse binding poses emphasizes the safety profile of apigenin. Conclusions: This molecular docking study provides valuable insights into the potential therapeutic role of apigenin in mitigating molecular pathways implicated in neurological disorders. Further in vitro and in vivo investigations are warranted to validate and elucidate the neuroprotective mechanisms of apigenin, paving the way for its development as a promising treatment option for various neurological conditions.

15 January 2019 in International Journal of Developmental Disabilities
Verified
Journal Article
Closed access
MWMuhammad Wasim
Muhammad Wasim
HKHaq Nawaz Khan
Haq Nawaz Khan
HAHina Ayesha
Hina Ayesha
FAFazli Rabbi Awan
Fazli Rabbi Awan
Objectives: Inborn errors of metabolism (IEMs) are rare genetic disorders. Generally, IEMs are untreatable; however, some IEMs causing intellectual disability are potentially treatable if diagnosed earlier. In this study, levels of some clinically important biochemical parameters in intellectually disabled children suspected for IEMs were tested to see their association with intellectual disability, which could be helpful in preliminary screening. Methods: This comparative cross-sectional observational study was carried out from 2014 to 2017. Blood samples from 800 boys and girls (aged 4–24 years) were collected, of which 391 were healthy (IQ >90) and 409 were intellectually disabled (IQ <70) children with unknown cause. Clinically important (Liver and kidney enzymes etc.) biochemical parameters were analyzed in sera samples using commercial kits on semi-automated clinical chemistry analyzer. Results: Serum analysis showed the levels of ALP (p < 0.00001), ASAT (p = 0.001), ALAT (p = 0.016), albumin (p < 0.001), uric acid (p < 0.001), cholesterol (p < 0.001), triglycerides (p < 0.001), and hemoglobin (p = 0.005) were significantly different between healthy and intellectually disabled children. Conclusion: Changes in the liver function test and lipid profile parameters were significantly different in children with intellectual disability; however, it requires further detailed analysis for complete characterization of these diseases.

31 October 2023 in Rare
Verified
Journal Article
Open access
MWMuhammad Wasim
Muhammad Wasim
HKHaq Nawaz Khan
Haq Nawaz Khan
HAHina Ayesha
Hina Ayesha
FAFazli Rabbi Awan
Fazli Rabbi Awan